Trial Profile
Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa university
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2020
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Pulmonary embolism
- Focus Therapeutic Use
- Acronyms Edo-warivashi study in showa university
- 14 Dec 2015 New trial record